| 4-amino-N-(4-methoxybenzyl)benzenesulfonamide |
4-氨基-N-(4-甲氧基苄基)苯磺酰胺 |
436091-90-6 |
| AA41612 |
化合物AA41612 |
433690-62-1 |
| Pentanoic acid, 2-methyl-, (R)- |
Pentanoic acid, 2-methyl-, (R)- |
49642-47-9 |
| 5'-Azido-5'-deoxyguanosine |
5'-叠氮基-5'-脱氧鸟苷 |
42204-44-4 |
| 9H-Cyclohepta[b]pyridin-9-one, 5,6,7,8-tetrahydro- |
9H-Cyclohepta[b]pyridin-9-one, 5,6,7,8-tetrahydro- |
41043-13-4 |
| NSC 108608 |
5'-氨基-5'-脱氧鸟苷 |
4099-84-7 |
| (2S,4R)-4-Methylpyrrolidine-2-carboxylic acid hydrochloride |
反式-4-甲基-L-脯氨酸盐酸盐 |
365280-18-8 |
| RBC10 |
RBC10 |
362503-73-9 |
| N-(4-butylphenyl)-5-nitrofuran-2-carboxamide |
化合物C-170 |
346691-38-1 |
| NCGC00262650 |
NCGC00262650 |
344359-25-7 |
| 2-Pentenoic acid, 4-[[(2S)-2-[3-[[(5-methyl-3-isoxazolyl)carbonyl]amino]-2-oxo-1(2H)-pyridinyl]-1-oxo-4-pentyn-1-yl]amino]-5-[(3S)-2-oxo-3-pyrrolidinyl]-, ethyl ester, (2E,4S)- |
AG-7404 |
343565-99-1 |
| NCRW0005-F05 |
化合物NCRW0005-F05 |
342779-66-2 |
| TM5007 |
化合物TM5007 |
342595-05-5 |
| AC-LEU-PRO-PHE-PHE-ASP-NH2 |
AC-LEU-PRO-PHE-PHE-ASP-NH2 |
339990-02-2 |
| Briakinumab |
Briakinumab |
339308-60-0 |
| tadocizumab |
tadocizumab |
339086-80-5 |
| N-(6-Chloropyridin-3-Yl)-3,4-Difluorobenzamide |
325457-89-4 |
325457-89-4 |
| IQ 3 |
IQ 3 |
312538-03-7 |
| SR31527 |
SR31527 |
311814-78-5 |
| ethyl 2-(2-(6,7-dimethyl-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamido)-4,5-dimethylthiophene-3-carboxylate |
NMDI14 |
307519-88-6 |
QQ
微信
